申请人:UNIV WITWATERSRAND JHB
公开号:WO2014041489A2
公开(公告)日:2014-03-20
The present invention relates to a pharmaceutical dosage form which may comprise carbamoyl glycinated chitosan, and particularly it relates to a pharmaceutical dosage form comprising the novel polymer in a lyophilized polymeric wafer form which shows rapid disintegration and dissolution characteristics in use.